Sasagu Kurozumi

Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival

Chitra Joseph, Mansour Alsaleem, Nnamdi Orah et al. · Breast Cancer Research and Treatment · 2020 · 134 citations · Full text

Medicine, Cell Biology, Oncology +17

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer

Ayaka Katayama, Islam M. Miligy, Sho Shiino et al. · Modern Pathology · 2021 · 87 citations · Full text

Medicine, Oncology, Breast Oncology +13

Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index

Sasagu Kurozumi, Hiroshi Matsumoto, Yuji Hayashi et al. · BMC Cancer · 2017 · 70 citations · Full text

Medicine, Oncology, Breast Oncology +16

ER, PgR, Ki67, p27Kip1, and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab

Sasagu Kurozumi, Kenichi Inoue, Hiroyuki Takei et al. · BMC Cancer · 2015 · 69 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

RNA‐sequence‐based microRNA expression signature in breast cancer: tumor‐suppressive <i>miR‐101‐5p</i> regulates molecular pathogenesis

Hiroko Toda, Naohiko Seki, Sasagu Kurozumi et al. · Molecular Oncology · 2019 · 66 citations · Full text

Medicine, Molecular Biology, Oncology +17